Loading...
Siegfried Holding AG
SGFEF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$114.35
$0.00(0.00%)
Siegfried Holding AG (SGFEF) Financial Performance & Income Statement Overview
Review Siegfried Holding AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1.82%
↑ 1.82%
Operating Income Growth
15.80%
↑ 15.80%
Net Income Growth
41.93%
↑ 41.93%
Operating Cash Flow Growth
-19.09%
↓ 19.09%
Operating Margin
13.98%
↑ 13.98%
Gross Margin
25.87%
↑ 25.87%
Net Profit Margin
7.80%
↑ 7.80%
ROE
10.61%
↑ 10.61%
ROIC
11.04%
↑ 11.04%
Siegfried Holding AG (SGFEF) Income Statement & Financial Overview
Review Siegfried Holding AG's (SGFEF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $619.90M | $664.44M | $332.22M | $607.05M |
| Cost of Revenue | $460.38M | $491.72M | $245.86M | $459.37M |
| Gross Profit | $159.52M | $172.72M | $86.36M | $147.69M |
| Gross Profit Ratio | $0.26 | $0.26 | $0.26 | $0.24 |
| R&D Expenses | $21.72M | $21.57M | $10.79M | $22.93M |
| SG&A Expenses | $50.65M | $28.60M | $28.60M | $49.40M |
| Operating Expenses | $71.66M | $80.99M | $46.27M | $72.33M |
| Total Costs & Expenses | $532.05M | $572.71M | $292.13M | $531.70M |
| Interest Income | $2.53M | $325000.00 | $2.33M | $245000.00 |
| Interest Expense | $4.79M | $5.19M | $0.00 | $4.30M |
| Depreciation & Amortization | $42.84M | $21.12M | $21.12M | $38.54M |
| EBITDA | $130.70M | $67.83M | $67.83M | $113.89M |
| EBITDA Ratio | $0.21 | $0.10 | $0.20 | $0.19 |
| Operating Income | $87.86M | $91.73M | $46.72M | $75.35M |
| Operating Income Ratio | $0.14 | $0.14 | $0.14 | $0.12 |
| Other Income/Expenses (Net) | $2.15M | -$53.97M | -$8.96M | -$37.92M |
| Income Before Tax | $90.003M | $37.76M | $37.76M | $74.86M |
| Income Before Tax Ratio | $0.15 | $0.06 | $0.11 | $0.12 |
| Income Tax Expense | $18.73M | $9.02M | $9.02M | $19.65M |
| Net Income | $71.38M | $28.74M | $28.74M | $55.22M |
| Net Income Ratio | $0.12 | $0.04 | $0.09 | $0.09 |
| EPS | $16.64 | $6.77 | $6.61 | $13.00 |
| Diluted EPS | $16.58 | $6.61 | $6.61 | $12.99 |
| Weighted Avg Shares Outstanding | $4.29M | $4.24M | $4.35M | $4.25M |
| Weighted Avg Shares Outstanding (Diluted) | $4.31M | $4.35M | $4.35M | $4.25M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan